Bisphosphonates for treatment of severe idiopathic infantile hypercalcemia.
暂无分享,去创建一个
[1] M. Konrad,et al. Intravenous pamidronate in the treatment of severe idiopathic infantile hypercalcemia. , 2013, Iranian journal of kidney diseases.
[2] S. Heshmatollah,et al. Comparison of Alendronate and Pamidronate on Bone Loss in Kidney Transplant Patients for the First 6 Months of Transplantation , 2011 .
[3] M. Levine,et al. Hypercalcemia in children and adolescents , 2010, Current opinion in pediatrics.
[4] J. Molnar,et al. Bisphosphonate use in women and the risk of atrial fibrillation: a systematic review and meta-analysis. , 2010, International journal of cardiology.
[5] I. Imaz,et al. Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis , 2010, Osteoporosis International.
[6] B. Oliveri,et al. Intravenous bisphosphonate treatment and pregnancy: its effects on mother and infant bone health , 2010, Osteoporosis International.
[7] E. Prommer. Toxicity of bisphosphonates. , 2009, Journal of palliative medicine.
[8] F. Assadi. Hypercalcemia: an evidence-based approach to clinical cases. , 2009, Iranian journal of kidney diseases.
[9] L. Samson-Fang,et al. Effects of bisphosphonates in children with osteogenesis imperfecta: an AACPDM systematic review , 2009, Developmental medicine and child neurology.
[10] Sonal Singh,et al. Bisphosphonates and Atrial Fibrillation , 2009, Drug safety.
[11] S. Legrand,et al. Narrative Review: Furosemide for Hypercalcemia: An Unproven yet Common Practice , 2008, Annals of Internal Medicine.
[12] M. Santiago,et al. The use of bisphosphonate in the treatment of avascular necrosis: a systematic review , 2008, Clinical Rheumatology.
[13] N. Watts,et al. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy , 2008, Osteoporosis International.
[14] F. Santos,et al. Clinical use of bisphosphonates in children , 2007 .
[15] J. Kalmar,et al. Systematic Review: Bisphosphonates and Osteonecrosis of the Jaws , 2006, Annals of Internal Medicine.
[16] D. Ashcroft,et al. Systematic review of effectiveness of bisphosphonates in treatment of low bone mineral density and fragility fractures in juvenile idiopathic arthritis , 2006, Archives of Disease in Childhood.